April tip sheet from Cedars-Sinai Medical Center

April 24, 2001

Cardiologist Noel Bairey Merz, M.D., brings multi-specialty perspective to her new role as Director of Women's Health Program at Cedars-Sinai

Cardiologist Noel Bairey Merz, M.D., currently director of Cedars-Sinai Medical Center's Preventive and Rehabilitative Cardiac Center, has been appointed to direct the Women's Health Program and hold the Women's Guild Chair in Women's Health. "Through her guidance, Cedars-Sinai will have a tremendous impact upon the health and well-being of the women in our community, providing cutting-edge benefits in terms of research, clinical care and education," says Shlomo Melmed, M.D., Senior Vice President for Academic Affairs, and Director of the Burns & Allen Research Institute.

Temodar clinical trial studies effectiveness of first new FDA-approved brain cancer fighting drug in more than 20 years

A clinical trial to study the effectiveness of Temodar (temozolomide), the first new brain cancer fighting drug to receive FDA approval in more than 20 years, is underway at Cedars-Sinai Medical Center's Maxine Dunitz Neurosurgical Institute in Los Angeles. The study will focus on patients with mixed gliomas or oligodendroglial tumors and is expected to last approximately two and one-half years. Although this is presently a single-center clinical trial, other facilities are expected to join the study as it progresses.

Very low doses of a potent new drug reduces the complications of bone metastases in patients with metastatic breast cancer and multiple myeloma

Researchers at Cedars-Sinai Medical Center report that very low doses of a potent new drug called zoledronic acid reduces the complications that arise from multiple myeloma and breast cancer that has spread to the bone. The study, published in the April 1st issue of the journal, Cancer, shows that a five-minute infusion of zoledronic acid works as effectively as much higher doses of a similar therapy called pamidronate, which is given over a two-hour time period. Bone metastasis occurs in approximately 50 percent of patients with cancers that have spread to other parts of the body, but is particularly prevalent in multiple myeloma and metastatic cancers of the breast, prostate, lung, kidney and thyroid.

Seeing variations in their own body temperatures, students attending 2001 'brainworks' at cedars-sinai's maxine dunitz neurosurgical institute will learn about thermal imaging

On May 30, 2001, 120 seventh- and eighth-grade students from Los Angeles-area schools will learn how researchers at Cedars-Sinai's Maxine Dunitz Neurosurgical Institute are adapting declassified military technology for medical uses. Scientists at the Institute are using thermal imagers to detect brain tumors and malformed arteries in the brain that can cause strokes.

Los Angeles marathon runner defies statistics to survive heart attack, oxygen deprivation and head injury with no long-term deficits

Slightly more than seven weeks after collapsing from a heart attack while running the Los Angeles Marathon, 49-year-old John Davidson has made what doctors call a miraculous recovery. Despite requiring CPR from fellow runners at the scene for approximately 15-17 minutes, then being in a coma for six days, Davidson has no discernible cardiac damage on EKG, on echocardiogram, nor on examination. And there's no neurologic damage.

Heart transplant recipient finds opportunities to share insights and hope when he goes to work in Cedars-Sinai's liver and kidney transplant program

This June, Glenn Matsuki, Silver Lake, CA, will celebrate the sixth anniversary of his heart transplant. What makes him truly unique is that he also works in the organ transplant arena - serving for the past year as management assistant for Steven D. Colquhoun, M.D., transplant surgeon and Program Director for the Center for Liver Disease and Transplantation at Cedars-Sinai Medical Center. Having first-hand experience as a transplant recipient, gives him unique insights into the needs and concerns of patients facing a liver or kidney transplant. He is available for interviews.
To pursue any of these story ideas, please call 310-423-4767. Thank you.

Cedars-Sinai Medical Center

Related Breast Cancer Articles from Brightsurf:

Oncotarget: IGF2 expression in breast cancer tumors and in breast cancer cells
The Oncotarget authors propose that methylation of DVDMR represents a novel epigenetic biomarker that determines the levels of IGF2 protein expression in breast cancer.

Breast cancer: AI predicts which pre-malignant breast lesions will progress to advanced cancer
New research at Case Western Reserve University in Cleveland, Ohio, could help better determine which patients diagnosed with the pre-malignant breast cancer commonly as stage 0 are likely to progress to invasive breast cancer and therefore might benefit from additional therapy over and above surgery alone.

Partial breast irradiation effective treatment option for low-risk breast cancer
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G.

Breast screening linked to 60 per cent lower risk of breast cancer death in first 10 years
Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women.

More clues revealed in link between normal breast changes and invasive breast cancer
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process -- changes in mammary glands to accommodate breastfeeding -- uses a molecular process believed to contribute to survival of pre-malignant breast cells.

Breast tissue tumor suppressor PTEN: A potential Achilles heel for breast cancer cells
A highly collaborative team of researchers at the Medical University of South Carolina and Ohio State University report in Nature Communications that they have identified a novel pathway for connective tissue PTEN in breast cancer cell response to radiotherapy.

Computers equal radiologists in assessing breast density and associated breast cancer risk
Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic.

Blood test can effectively rule out breast cancer, regardless of breast density
A new study published in PLOS ONE demonstrates that Videssa® Breast, a multi-protein biomarker blood test for breast cancer, is unaffected by breast density and can reliably rule out breast cancer in women with both dense and non-dense breast tissue.

Study shows influence of surgeons on likelihood of removal of healthy breast after breast cancer dia
Attending surgeons can have a strong influence on whether a patient undergoes contralateral prophylactic mastectomy after a diagnosis of breast cancer, according to a study published by JAMA Surgery.

Young breast cancer patients undergoing breast conserving surgery see improved prognosis
A new analysis indicates that breast cancer prognoses have improved over time in young women treated with breast conserving surgery.

Read More: Breast Cancer News and Breast Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.